BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CMS QIN-QIO - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://qi.ipro.org
X-WR-CALDESC:Events for CMS QIN-QIO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T120000
DTEND;TZID=America/New_York:20231115T130000
DTSTAMP:20260611T014725
CREATED:20231013T143234Z
LAST-MODIFIED:20231016T140817Z
UID:36630-1700049600-1700053200@qi.ipro.org
SUMMARY:Anticoagulation Learning Circle
DESCRIPTION:THE IPRO QIN-QIO INVITES YOU\nTO PARTICIPATE IN OUR\nAnticoagulation Learning Circle \n\n\nAnticoagulants (blood thinners) are important for preventing and treating blood clots but are associated with an increased risk for bleeding.\nUsing anticoagulants safely requires a careful balance between risks and benefits.\nAmong older adults\, oral anticoagulants are the most common causes of adverse drug events (ADEs) leading to emergency room visits and emergent hospitalizations. Oral anticoagulants include warfarin and the direct-acting oral anticoagulants (DOACs) such as apixaban\, dabigatran\, edoxaban\, and rivaroxaban.’\nBleeding from oral anticoagulants resulted in approximately 235\,000 emergency department visits.\nOlder adults (≥65 years of age) were involved in approximately 80% of DOAC-related bleeding visits and 77% of warfarin-related bleeding visits.\nDOACs contributed to approximately 40% of estimated oral anticoagulant bleeding visits. (bit.ly/45EFF8v)\n\nThe Anticoagulation Learning Circle offers a forum for education and sharing of resources and best practices with a goal for all participants to benefit from the wisdom and experience of the group. \nJoin other clinicians and a subject matter expert in conversations focused on anticoagulation stewardship. \n\nThis Learning Circle will provide you the opportunity to: \n\nReview anticoagulant Adverse Drug Events (ADEs) and associated risk factors.\nDiscuss actual case studies from the practice of a specialist with experience in anticoagulation stewardship.\nUse a template Action Plan to assess anticoagulation management and evaluate outcome measures.\nPose questions about anticoagulation stewardship to a subject matter expert.
URL:https://qi.ipro.org/upcoming-events/anticoagulation-learning-circle/
LOCATION:Online via WebEx
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T153000
DTEND;TZID=America/New_York:20231115T163000
DTSTAMP:20260611T014725
CREATED:20230808T200057Z
LAST-MODIFIED:20230808T200057Z
UID:36266-1700062200-1700065800@qi.ipro.org
SUMMARY:Boosters and Beyond: Geriatric Bootcamp: LTC: Staff Retention and Training (Live Replay)
DESCRIPTION:Topic: Boosters and Beyond: Geriatric Bootcamp: LTC: Staff Retention and Training (Live Replay) \nDescription: Join us to learn strategies to train and retain long-term care staff.
URL:https://qi.ipro.org/upcoming-events/boosters-and-beyond-geriatric-bootcamp-ltc-staff-retention-and-training-live-replay/
LOCATION:Online via Zoom
CATEGORIES:Free event,Nursing Home
END:VEVENT
END:VCALENDAR